focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPP.L Regulatory News (APP)

  • There is currently no data for APP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Appreciate Group (Initiation of coverage): Solid core + digital disruption = unique model

1 Sep 2021 10:55

Hardman & Co Research Hardman & Co Research: Appreciate Group (Initiation of coverage): Solid core + digital disruption = unique model 01-Sep-2021 / 10:55 GMT/BST


Hardman & Co Research (Initiation of coverage):

Solid core + digital disruption = unique model

 

Appreciate (APP) gives investors potentially explosive growth through new digital offerings in the gifting/engagement markets, where its share is just 3%. This is uniquely combined with a dominant 71% market share in the consumer pre-paid Xmas savings market, which brings decades of key partnership management experience. FY'21-22 has been a challenging period for Xmas savings, but APP is generating the profits to fund the digital growth. Digitalisation not only opens new markets (a Europe comparator quadrupled sales in two years), but also improves efficiency and customer service, and typically sees share ratings double those of non-digital models.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/solid-core-digital-disruption-unique-model/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Mark Thomas

+44(0)20 3693 7075

 

mt@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1230367 01-Sep-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
26th Apr 20187:00 amRNSTrading Update
28th Mar 20187:00 amRNSDirectorate Change
12th Feb 201811:35 amRNSHolding(s) in Company
12th Feb 201811:32 amRNSHolding(s) in Company
30th Jan 201811:27 amRNSConfirmation of CEO Appointment
19th Jan 20182:55 pmRNSDirector/PDMR Shareholding
21st Dec 20171:00 pmRNSDirectorate Change
28th Nov 20177:00 amRNSHalf-year Report
15th Nov 20177:00 amRNSAppointment of CEO
31st Oct 20179:00 amRNSNotice of Results
3rd Oct 20176:21 pmRNSHolding(s) in Company
2nd Oct 20175:27 pmRNSDirector/PDMR Shareholding
21st Sep 20172:14 pmRNSResult of AGM
21st Sep 20177:00 amRNSAGM Statement
15th Sep 20173:06 pmRNSDirector Declaration
17th Aug 201711:23 amRNSHolding(s) in Company
4th Jul 20173:07 pmRNSHolding(s) in Company
28th Jun 201711:23 amRNSHolding(s) in Company
23rd Jun 20172:30 pmRNSDirector/PDMR Shareholding and Total Voting Rights
13th Jun 20177:00 amRNSFinal Results
16th May 20177:00 amRNSPark Group Launches Global Reward Capability
10th Apr 201711:58 amRNSHolding(s) in Company
6th Apr 20177:00 amRNSTrading Update
5th Apr 20173:22 pmRNSHolding(s) in Company
25th Jan 20173:13 pmRNSDirector/PDMR Shareholding
9th Jan 20177:00 amRNSPark Gains Mastercard Issuing Licence
9th Dec 20165:33 pmRNSDirector/PDMR Shareholding
6th Dec 20165:29 pmRNSTotal Voting Rights
6th Dec 201611:54 amRNSHolding(s) in Company
6th Dec 201610:46 amRNSHolding(s) in Company
1st Dec 20167:00 amRNSflexecash® Cards Now Accepted Online by Argos
29th Nov 20167:00 amRNSHalf-year Report
1st Nov 20169:00 amRNSNotice of Results
5th Oct 20167:00 amRNSAcquisition
26th Sep 20161:48 pmRNSHolding(s) in Company
22nd Sep 201612:21 pmRNSResult of AGM
22nd Sep 20167:01 amRNSAGM Statement
22nd Sep 20167:00 amRNSDirectorate Change
3rd Aug 201612:15 pmRNSHolding(s) in Company
28th Jul 20163:02 pmRNSPosting of Annual Report and Accounts
27th Jul 20164:40 pmRNSSecond Price Monitoring Extn
27th Jul 20164:35 pmRNSPrice Monitoring Extension
1st Jul 201610:30 amRNSBoard Update
14th Jun 20167:00 amRNSFinal Results
17th May 20164:41 pmRNSSecond Price Monitoring Extn
17th May 20164:35 pmRNSPrice Monitoring Extension
16th May 20164:40 pmRNSSecond Price Monitoring Extn
16th May 20164:35 pmRNSPrice Monitoring Extension
20th Apr 20168:00 amRNSNotice of Results
13th Apr 20163:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.